EW

Edwards Lifesciences
D

EW

Arincen78/100B

Edwards Lifesciences stock buybacks 1999–2026

Edwards Lifesciences spent 138.90M USD buying back its shares in Q3 FY2026, the three months to 30 September 2026, down 11.5% on the same quarter a year before. Edwards Lifesciences spent 754.60M USD buying back its shares over the last twelve months, up 603.9% on the twelve months before. In fiscal year 2025 it spent 893.40M USD, down 22.9% on the year before.

Last updated 10 Nov 2026 · Next report 9 Feb 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 2026754.60M+603.92%—1.42B
FY202531 Dec 2025893.40M-22.94%0.001.34B
FY202431 Dec 20241.16B+31.81%0.00289.90M
FY202331 Dec 2023879.60M-49.07%0.00629.50M
FY202231 Dec 20221.73B+236.80%0.00953.40M
FY202131 Dec 2021512.80M-18.00%0.001.40B
FY202031 Dec 2020625.40M+137.52%0.00647.00M
FY201931 Dec 2019263.30M-66.90%0.00901.00M
FY201831 Dec 2018795.50M+4.22%0.00685.10M
FY201731 Dec 2017763.30M+15.25%0.00825.20M
FY201631 Dec 2016662.30M+136.45%0.00487.00M
FY201531 Dec 2015280.10M-6.91%0.00443.20M
FY201431 Dec 2014300.90M-39.44%0.00928.60M
FY201331 Dec 2013496.90M+44.41%0.00362.60M
FY201231 Dec 2012344.10M+13.41%0.00246.10M
FY201131 Dec 2011303.40M+51.70%0.00223.90M
FY201031 Dec 2010200.00M+109.42%0.00188.40M
FY200931 Dec 200995.50M-68.84%0.00101.30M
FY200831 Dec 2008306.50M+134.15%0.0075.20M
FY200731 Dec 2007130.90M-10.28%0.00147.70M
FY200631 Dec 2006145.90M+172.71%0.00171.40M
FY200531 Dec 200553.50M-9.48%0.0088.30M
FY200431 Dec 200459.10M+19.64%0.00138.10M
FY200331 Dec 200349.40M+60.39%0.0084.40M
FY200231 Dec 200230.80M—0.0079.90M
FY200131 Dec 20010.00—0.0063.00M
FY200031 Dec 20000.00—0.0091.00M
FY199931 Dec 19990.00—0.00134.00M

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Edwards Lifesciences's buybacks

Source: Financial Modeling Prep